Pediatric Hearing Loss Management in the COVID‐19 Era: Possible Consequences and Resources for the Next Future

Brotto, Davide; Sorrentino, Flavia; Favaretto, Niccolò; Bovo, Roberto; Trevisi, Patrizia

doi:10.1177/01945998211012677

Cited by 4 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The COVID-19 pandemic has affected pediatric otolaryngology patients and practices. [167][168][169] Corticosteroids are frequently indicated in children with airway compromise and laryngotracheal disorders. 170,171 They may also be utilized in sinonasal disorders and perioperative care.…”

Section: Pediatric Considerationsmentioning

confidence: 99%

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 Era

Chang

McCoul

Briggs

et al. 2021

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

Objective To offer pragmatic, evidence-informed advice on administering corticosteroids in otolaryngology during the coronavirus disease 2019 (COVID-19) pandemic, considering therapeutic efficacy, potential adverse effects, susceptibility to COVID-19, and potential effects on efficacy of vaccination against SARS-CoV-2, which causes COVID-19. Data Sources PubMed, Cochrane Library, EMBASE, CINAHL, and guideline databases. Review Methods Guideline search strategies, supplemented by database searches on sudden sensorineural hearing loss (SSNHL), idiopathic facial nerve paralysis (Bell’s palsy), sinonasal polyposis, laryngotracheal disorders, head and neck oncology, and pediatric otolaryngology, prioritizing systematic reviews, randomized controlled trials, and COVID-19–specific findings. Conclusions Systemic corticosteroids (SCSs) reduce long-term morbidity in individuals with SSNHL and Bell’s palsy, reduce acute laryngotracheal edema, and have benefit in perioperative management for some procedures. Topical or locally injected corticosteroids are preferable for most other otolaryngologic indications. SCSs have not shown long-term benefit for sinonasal disorders. SCSs are not a contraindication to vaccination with COVID-19 vaccines approved by the US Food and Drug Administration. The Centers for Disease Control and Prevention noted that these vaccines are safe for immunocompromised patients. Implications for Practice SCS use for SSNHL, Bell’s palsy, laryngotracheal edema, and perioperative care should follow prepandemic standards. Local or topical corticosteroids are preferable for most other otolaryngologic indications. Whether SCSs attenuate response to vaccination against COVID-19 or increase susceptibility to SARS-CoV-2 infection is unknown. Immunosuppression may lower vaccine efficacy, so immunocompromised patients should adhere to recommended infection control practices. COVID-19 vaccination with Pfizer-BioNTech, Moderna, or Johnson & Johnson vaccines is safe for immunocompromised patients.

show abstract

Section: Pediatric Considerationsmentioning

confidence: 99%

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 Era

Chang

McCoul

Briggs

et al. 2021

Otolaryngol.--head neck surg.

View full text Add to dashboard Cite

show abstract

Remote Check as a tele-health instrument for cochlear implant recipients: Analysis of impact and feasibility of application.

Sorrentino,

Cazzador,

Gazzola

et al. 2024

American Journal of Otolaryngology

View full text Add to dashboard Cite

Improving Auditory Perception in Pediatric Single-Sided Deafness: Use of Cochlear Implants' Direct Connection for Remote Speech Perception Rehabilitation

et al. 2023

View full text Add to dashboard Cite

Purpose: Unilateral cochlear implants (CIs) can restore binaural hearing in single-sided deafness (SSD). Direct stimulation of the CI can be obtained via the Bluetooth connection of a device to the CI, thus excluding the typical-hearing ear. This study aims to investigate the use of CI connectivity features as a rehabilitative strategy in a small cohort of children affected by SSD. Method: A newly developed training protocol was presented to children with SSD who have less than 2 years of experience with CI. We developed a user-friendly and short-term (six sessions within 20 days) training protocol for speech perception that patients themselves can manage independently at home using CI connectivity systems. Children were telematically tested before and after the training by trained speech and language therapists. Results: Four patients met the inclusion criteria. They all showed better results in the final online assessment, when compared with the initial one. Conclusions: To our knowledge, this is the first clinical focus article presenting an auditory training protocol for SSD patients with CI using the Bluetooth connectivity systems for teletherapy. The results, although preliminary, support the efficacy of this rehabilitative strategy. Further research is needed to support our findings.

show abstract

Pediatric Hearing Loss Management in the COVID‐19 Era: Possible Consequences and Resources for the Next Future

Cited by 4 publications

References 5 publications

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 Era

Corticosteroid Use in Otolaryngology: Current Considerations During the COVID‐19 Era

Remote Check as a tele-health instrument for cochlear implant recipients: Analysis of impact and feasibility of application.

Improving Auditory Perception in Pediatric Single-Sided Deafness: Use of Cochlear Implants' Direct Connection for Remote Speech Perception Rehabilitation

Contact Info

Product

Resources

About